Condition: Heart Failure · Heart Failure With Preserved Ejection Fraction · Heart Failure With Mid Range Ejection Fraction · Sponsor: Impulse Dynamics
The AIM HIGHer Clinical Trial will evaluate the safety and efficacy of Cardiac Contractility Modulation (CCM) therapy in patients with heart failure with LVEF ≥40% and ≤70%.
This description comes directly from the study's public registry record.
Gary Cranke · (856) 642-9933 · aimhigher@impulsedynamics.com
Always discuss trial participation with your own doctor first.
| Grandview Medical Group Research, LLC | Birmingham, Alabama, United States | Recruiting |
| CardioVascular Associates of Mesa | Mesa, Arizona, United States | Recruiting |
| Chan Heart Rhythm Institute | Mesa, Arizona, United States | Recruiting |
| Southwest Cardiovascular Associates | Mesa, Arizona, United States | Recruiting |
| Arizona Heart Rhythm | Phoenix, Arizona, United States | Recruiting |
| Cardiovascular Consultants, Ltd | Phoenix, Arizona, United States | Recruiting |
| HonorHealth | Scottsdale, Arizona, United States | Recruiting |
| Pima Heart and Vascular | Tuscon, Arizona, United States | Recruiting |
| John Muir Health | Concord, California, United States | Recruiting |
| University of California San Diego | La Jolla, California, United States | Recruiting |
| USC Keck School of Medicine | Los Angeles, California, United States | Recruiting |
| Cedars Sinai Medical Center | Los Angeles, California, United States | Recruiting |
+ 93 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05064709